Global IL-17 Monoclonal Antibody Injections Market Growth 2026-2032

June 2026 | 83 pages | ID: GDD6AAE1E85EEN
LP Information

Abstracts

The global IL-17 Monoclonal Antibody Injections market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

IL-17 monoclonal antibody injection refers to a monoclonal antibody drug developed by biotechnology that targets interleukin-17 (IL-17) and is used to treat certain autoimmune diseases such as psoriasis and rheumatoid arthritis. These drugs reduce inflammatory responses by inhibiting the action of IL-17.

United States market for IL-17 Monoclonal Antibody Injections is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for IL-17 Monoclonal Antibody Injections is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for IL-17 Monoclonal Antibody Injections is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key IL-17 Monoclonal Antibody Injections players cover Novartis, UCB, Eli Lilly and Co., AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?IL-17 Monoclonal Antibody Injections Industry Forecast? looks at past sales and reviews total world IL-17 Monoclonal Antibody Injections sales in 2025, providing a comprehensive analysis by region and market sector of projected IL-17 Monoclonal Antibody Injections sales for 2026 through 2032. With IL-17 Monoclonal Antibody Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IL-17 Monoclonal Antibody Injections industry.

This Insight Report provides a comprehensive analysis of the global IL-17 Monoclonal Antibody Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IL-17 Monoclonal Antibody Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IL-17 Monoclonal Antibody Injections market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IL-17 Monoclonal Antibody Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IL-17 Monoclonal Antibody Injections.

This report presents a comprehensive overview, market shares, and growth opportunities of IL-17 Monoclonal Antibody Injections market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Human Origin
• Rat Origin
• Other

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novartis
• UCB
• Eli Lilly and Co.
• AstraZeneca

Key Questions Addressed in this Report
What is the 10-year outlook for the global IL-17 Monoclonal Antibody Injections market?
What factors are driving IL-17 Monoclonal Antibody Injections market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IL-17 Monoclonal Antibody Injections market opportunities vary by end market size?
How does IL-17 Monoclonal Antibody Injections break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global IL-17 Monoclonal Antibody Injections Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for IL-17 Monoclonal Antibody Injections by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for IL-17 Monoclonal Antibody Injections by Country/Region, 2021, 2025 & 2032
2.2 IL-17 Monoclonal Antibody Injections Segment by Type
  2.2.1 Human Origin
  2.2.2 Rat Origin
  2.2.3 Other
  2.2.4 IL-17 Monoclonal Antibody Injections Sales by Type
    2.2.4.1 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2026)
    2.2.4.2 Global IL-17 Monoclonal Antibody Injections Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global IL-17 Monoclonal Antibody Injections Sale Price by Type (2021-2026)
2.3 IL-17 Monoclonal Antibody Injections Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 IL-17 Monoclonal Antibody Injections Sales by Application
    2.3.4.1 Global IL-17 Monoclonal Antibody Injections Sale Market Share by Application (2021-2026)
    2.3.4.2 Global IL-17 Monoclonal Antibody Injections Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global IL-17 Monoclonal Antibody Injections Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global IL-17 Monoclonal Antibody Injections Breakdown Data by Company
  3.1.1 Global IL-17 Monoclonal Antibody Injections Annual Sales by Company (2021-2026)
  3.1.2 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Company (2021-2026)
3.2 Global IL-17 Monoclonal Antibody Injections Annual Revenue by Company (2021-2026)
  3.2.1 Global IL-17 Monoclonal Antibody Injections Revenue by Company (2021-2026)
  3.2.2 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Company (2021-2026)
3.3 Global IL-17 Monoclonal Antibody Injections Sale Price by Company
3.4 Key Manufacturers IL-17 Monoclonal Antibody Injections Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers IL-17 Monoclonal Antibody Injections Product Location Distribution
  3.4.2 Players IL-17 Monoclonal Antibody Injections Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR IL-17 MONOCLONAL ANTIBODY INJECTIONS BY GEOGRAPHIC REGION

4.1 World Historic IL-17 Monoclonal Antibody Injections Market Size by Geographic Region (2021-2026)
  4.1.1 Global IL-17 Monoclonal Antibody Injections Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global IL-17 Monoclonal Antibody Injections Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IL-17 Monoclonal Antibody Injections Market Size by Country/Region (2021-2026)
  4.2.1 Global IL-17 Monoclonal Antibody Injections Annual Sales by Country/Region (2021-2026)
  4.2.2 Global IL-17 Monoclonal Antibody Injections Annual Revenue by Country/Region (2021-2026)
4.3 Americas IL-17 Monoclonal Antibody Injections Sales Growth
4.4 APAC IL-17 Monoclonal Antibody Injections Sales Growth
4.5 Europe IL-17 Monoclonal Antibody Injections Sales Growth
4.6 Middle East & Africa IL-17 Monoclonal Antibody Injections Sales Growth

5 AMERICAS

5.1 Americas IL-17 Monoclonal Antibody Injections Sales by Country
  5.1.1 Americas IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026)
  5.1.2 Americas IL-17 Monoclonal Antibody Injections Revenue by Country (2021-2026)
5.2 Americas IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026)
5.3 Americas IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC IL-17 Monoclonal Antibody Injections Sales by Region
  6.1.1 APAC IL-17 Monoclonal Antibody Injections Sales by Region (2021-2026)
  6.1.2 APAC IL-17 Monoclonal Antibody Injections Revenue by Region (2021-2026)
6.2 APAC IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026)
6.3 APAC IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe IL-17 Monoclonal Antibody Injections by Country
  7.1.1 Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026)
  7.1.2 Europe IL-17 Monoclonal Antibody Injections Revenue by Country (2021-2026)
7.2 Europe IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026)
7.3 Europe IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa IL-17 Monoclonal Antibody Injections by Country
  8.1.1 Middle East & Africa IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026)
  8.1.2 Middle East & Africa IL-17 Monoclonal Antibody Injections Revenue by Country (2021-2026)
8.2 Middle East & Africa IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026)
8.3 Middle East & Africa IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IL-17 Monoclonal Antibody Injections
10.3 Manufacturing Process Analysis of IL-17 Monoclonal Antibody Injections
10.4 Industry Chain Structure of IL-17 Monoclonal Antibody Injections

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 IL-17 Monoclonal Antibody Injections Distributors
11.3 IL-17 Monoclonal Antibody Injections Customer

12 WORLD FORECAST REVIEW FOR IL-17 MONOCLONAL ANTIBODY INJECTIONS BY GEOGRAPHIC REGION

12.1 Global IL-17 Monoclonal Antibody Injections Market Size Forecast by Region
  12.1.1 Global IL-17 Monoclonal Antibody Injections Forecast by Region (2027-2032)
  12.1.2 Global IL-17 Monoclonal Antibody Injections Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IL-17 Monoclonal Antibody Injections Forecast by Type (2027-2032)
12.7 Global IL-17 Monoclonal Antibody Injections Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis IL-17 Monoclonal Antibody Injections Product Portfolios and Specifications
  13.1.3 Novartis IL-17 Monoclonal Antibody Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments
13.2 UCB
  13.2.1 UCB Company Information
  13.2.2 UCB IL-17 Monoclonal Antibody Injections Product Portfolios and Specifications
  13.2.3 UCB IL-17 Monoclonal Antibody Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 UCB Main Business Overview
  13.2.5 UCB Latest Developments
13.3 Eli Lilly and Co.
  13.3.1 Eli Lilly and Co. Company Information
  13.3.2 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolios and Specifications
  13.3.3 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Eli Lilly and Co. Main Business Overview
  13.3.5 Eli Lilly and Co. Latest Developments
13.4 AstraZeneca
  13.4.1 AstraZeneca Company Information
  13.4.2 AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolios and Specifications
  13.4.3 AstraZeneca IL-17 Monoclonal Antibody Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 AstraZeneca Main Business Overview
  13.4.5 AstraZeneca Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. IL-17 Monoclonal Antibody Injections Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IL-17 Monoclonal Antibody Injections Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Human Origin
Table 4. Major Players of Rat Origin
Table 5. Major Players of Other
Table 6. Global IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units)
Table 7. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2026)
Table 8. Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2026) & ($ million)
Table 9. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021-2026)
Table 10. Global IL-17 Monoclonal Antibody Injections Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global IL-17 Monoclonal Antibody Injections Sale by Application (2021-2026) & (K Units)
Table 12. Global IL-17 Monoclonal Antibody Injections Sale Market Share by Application (2021-2026)
Table 13. Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2026) & ($ million)
Table 14. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021-2026)
Table 15. Global IL-17 Monoclonal Antibody Injections Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global IL-17 Monoclonal Antibody Injections Sales by Company (2021-2026) & (K Units)
Table 17. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Company (2021-2026)
Table 18. Global IL-17 Monoclonal Antibody Injections Revenue by Company (2021-2026) & ($ millions)
Table 19. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Company (2021-2026)
Table 20. Global IL-17 Monoclonal Antibody Injections Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers IL-17 Monoclonal Antibody Injections Producing Area Distribution and Sales Area
Table 22. Players IL-17 Monoclonal Antibody Injections Products Offered
Table 23. IL-17 Monoclonal Antibody Injections Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global IL-17 Monoclonal Antibody Injections Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global IL-17 Monoclonal Antibody Injections Sales Market Share Geographic Region (2021-2026)
Table 28. Global IL-17 Monoclonal Antibody Injections Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global IL-17 Monoclonal Antibody Injections Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Country/Region (2021-2026)
Table 32. Global IL-17 Monoclonal Antibody Injections Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units)
Table 35. Americas IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2026)
Table 36. Americas IL-17 Monoclonal Antibody Injections Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units)
Table 38. Americas IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units)
Table 39. APAC IL-17 Monoclonal Antibody Injections Sales by Region (2021-2026) & (K Units)
Table 40. APAC IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2021-2026)
Table 41. APAC IL-17 Monoclonal Antibody Injections Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units)
Table 43. APAC IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units)
Table 44. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units)
Table 45. Europe IL-17 Monoclonal Antibody Injections Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units)
Table 47. Europe IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of IL-17 Monoclonal Antibody Injections
Table 53. Key Market Challenges & Risks of IL-17 Monoclonal Antibody Injections
Table 54. Key Industry Trends of IL-17 Monoclonal Antibody Injections
Table 55. IL-17 Monoclonal Antibody Injections Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. IL-17 Monoclonal Antibody Injections Distributors List
Table 58. IL-17 Monoclonal Antibody Injections Customer List
Table 59. Global IL-17 Monoclonal Antibody Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global IL-17 Monoclonal Antibody Injections Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas IL-17 Monoclonal Antibody Injections Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC IL-17 Monoclonal Antibody Injections Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC IL-17 Monoclonal Antibody Injections Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe IL-17 Monoclonal Antibody Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa IL-17 Monoclonal Antibody Injections Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa IL-17 Monoclonal Antibody Injections Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global IL-17 Monoclonal Antibody Injections Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global IL-17 Monoclonal Antibody Injections Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global IL-17 Monoclonal Antibody Injections Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global IL-17 Monoclonal Antibody Injections Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novartis Basic Information, IL-17 Monoclonal Antibody Injections Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis IL-17 Monoclonal Antibody Injections Product Portfolios and Specifications
Table 75. Novartis IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. UCB Basic Information, IL-17 Monoclonal Antibody Injections Manufacturing Base, Sales Area and Its Competitors
Table 79. UCB IL-17 Monoclonal Antibody Injections Product Portfolios and Specifications
Table 80. UCB IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. UCB Main Business
Table 82. UCB Latest Developments
Table 83. Eli Lilly and Co. Basic Information, IL-17 Monoclonal Antibody Injections Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolios and Specifications
Table 85. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Eli Lilly and Co. Main Business
Table 87. Eli Lilly and Co. Latest Developments
Table 88. AstraZeneca Basic Information, IL-17 Monoclonal Antibody Injections Manufacturing Base, Sales Area and Its Competitors
Table 89. AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolios and Specifications
Table 90. AstraZeneca IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. AstraZeneca Main Business
Table 92. AstraZeneca Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of IL-17 Monoclonal Antibody Injections
Figure 2. IL-17 Monoclonal Antibody Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IL-17 Monoclonal Antibody Injections Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global IL-17 Monoclonal Antibody Injections Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IL-17 Monoclonal Antibody Injections Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IL-17 Monoclonal Antibody Injections Sales Market Share by Country/Region (2025)
Figure 10. IL-17 Monoclonal Antibody Injections Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Human Origin
Figure 12. Product Picture of Rat Origin
Figure 13. Product Picture of Other
Figure 14. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type in 2026
Figure 15. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021-2026)
Figure 16. IL-17 Monoclonal Antibody Injections Consumed in Hospital
Figure 17. Global IL-17 Monoclonal Antibody Injections Market: Hospital (2021-2026) & (K Units)
Figure 18. IL-17 Monoclonal Antibody Injections Consumed in Clinic
Figure 19. Global IL-17 Monoclonal Antibody Injections Market: Clinic (2021-2026) & (K Units)
Figure 20. IL-17 Monoclonal Antibody Injections Consumed in Other
Figure 21. Global IL-17 Monoclonal Antibody Injections Market: Other (2021-2026) & (K Units)
Figure 22. Global IL-17 Monoclonal Antibody Injections Sale Market Share by Application (2025)
Figure 23. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application in 2026
Figure 24. IL-17 Monoclonal Antibody Injections Sales by Company in 2026 (K Units)
Figure 25. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Company in 2026
Figure 26. IL-17 Monoclonal Antibody Injections Revenue by Company in 2026 ($ millions)
Figure 27. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Company in 2026
Figure 28. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Geographic Region in 2026
Figure 30. Americas IL-17 Monoclonal Antibody Injections Sales 2021-2026 (K Units)
Figure 31. Americas IL-17 Monoclonal Antibody Injections Revenue 2021-2026 ($ millions)
Figure 32. APAC IL-17 Monoclonal Antibody Injections Sales 2021-2026 (K Units)
Figure 33. APAC IL-17 Monoclonal Antibody Injections Revenue 2021-2026 ($ millions)
Figure 34. Europe IL-17 Monoclonal Antibody Injections Sales 2021-2026 (K Units)
Figure 35. Europe IL-17 Monoclonal Antibody Injections Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa IL-17 Monoclonal Antibody Injections Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa IL-17 Monoclonal Antibody Injections Revenue 2021-2026 ($ millions)
Figure 38. Americas IL-17 Monoclonal Antibody Injections Sales Market Share by Country in 2026
Figure 39. Americas IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2021-2026)
Figure 40. Americas IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2026)
Figure 41. Americas IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2026)
Figure 42. United States IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC IL-17 Monoclonal Antibody Injections Sales Market Share by Region in 2026
Figure 47. APAC IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2021-2026)
Figure 48. APAC IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2026)
Figure 49. APAC IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2026)
Figure 50. China IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 54. India IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe IL-17 Monoclonal Antibody Injections Sales Market Share by Country in 2026
Figure 58. Europe IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2021-2026)
Figure 59. Europe IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2026)
Figure 60. Europe IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2026)
Figure 61. Germany IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 62. France IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 63. UK IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2026)
Figure 69. Egypt IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries IL-17 Monoclonal Antibody Injections Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of IL-17 Monoclonal Antibody Injections in 2026
Figure 75. Manufacturing Process Analysis of IL-17 Monoclonal Antibody Injections
Figure 76. Industry Chain Structure of IL-17 Monoclonal Antibody Injections
Figure 77. Channels of Distribution
Figure 78. Global IL-17 Monoclonal Antibody Injections Sales Market Forecast by Region (2027-2032)
Figure 79. Global IL-17 Monoclonal Antibody Injections Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global IL-17 Monoclonal Antibody Injections Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global IL-17 Monoclonal Antibody Injections Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global IL-17 Monoclonal Antibody Injections Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global IL-17 Monoclonal Antibody Injections Revenue Market Share Forecast by Application (2027-2032)